Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Ecotype
Odontogenesis
Steroid 12-alpha-Hydroxylase
Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group.
Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide.
Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide. J Immunol. 2001 Jun 15; 166(12):7151-7.
View in:
PubMed
subject areas
Adenovirus E1A Proteins
Animals
Clonal Deletion
Diffusion
Epitopes, T-Lymphocyte
Female
Immune Tolerance
Injections, Subcutaneous
Kinetics
Lymphocyte Activation
Mice
Mice, Inbred C57BL
Oncogene Proteins, Viral
Organ Specificity
Papillomaviridae
Papillomavirus E7 Proteins
Peptide Fragments
Protein Binding
Time Factors
T-Lymphocytes, Cytotoxic
Tritium
Viral Vaccines
authors with profiles
Hans Schreiber
Stephen C. Meredith